Dorsey & Whitney Trust CO LLC Boosts Stock Position in Koninklijke Philips (NYSE:PHG)

Dorsey & Whitney Trust CO LLC grew its stake in shares of Koninklijke Philips (NYSE:PHG) by 3.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 11,401 shares of the technology company’s stock after buying an additional 427 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in Koninklijke Philips were worth $289,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. FMR LLC lifted its position in shares of Koninklijke Philips by 0.6% during the 3rd quarter. FMR LLC now owns 6,138,708 shares of the technology company’s stock valued at $200,859,000 after buying an additional 35,935 shares in the last quarter. Bank of Montreal Can lifted its holdings in Koninklijke Philips by 2,883.5% in the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock worth $32,157,000 after purchasing an additional 949,278 shares in the last quarter. IHT Wealth Management LLC purchased a new position in Koninklijke Philips in the 3rd quarter worth approximately $19,593,000. Raymond James Financial Inc. purchased a new position in Koninklijke Philips in the 4th quarter worth approximately $10,655,000. Finally, Bar Harbor Wealth Management lifted its holdings in Koninklijke Philips by 2.1% in the 4th quarter. Bar Harbor Wealth Management now owns 308,157 shares of the technology company’s stock worth $7,803,000 after purchasing an additional 6,281 shares in the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PHG has been the topic of a number of research analyst reports. BNP Paribas raised Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday. Finally, UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy”.

Koninklijke Philips Stock Down 0.0 %

Shares of PHG opened at $26.75 on Wednesday. The stock has a market capitalization of $25.15 billion, a price-to-earnings ratio of -31.85, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a 1 year low of $19.10 and a 1 year high of $32.91. The business’s 50 day simple moving average is $26.57 and its 200-day simple moving average is $27.92. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). The firm had revenue of $5.38 billion for the quarter, compared to analysts’ expectations of $5.10 billion. Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. As a group, equities analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The company also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be issued a dividend of $0.886 per share. The ex-dividend date is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips’s dividend payout ratio (DPR) is -89.29%.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.